Loading…
Lobbying Spend
—
Filings
19
Firms Hired
1
Active Period
2007–2011
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
America's Affordable Health Choices Act of 2009
2010 · first_quarter · Firm: DARLENE RICHESON & ASSOCIATES
H.R. 3200- Health Care Reform
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3200
America's Affordable Health Choices Act of 2009
2009 · fourth_quarter · Firm: DARLENE RICHESON & ASSOCIATES
H.R. 3200- Health Care Reform
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3200
America's Affordable Health Choices Act of 2009
2009 · third_quarter · Firm: DARLENE RICHESON & ASSOCIATES
H.R. 3200- Health Care Reform
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3200
Access for All America Act
2009 · second_quarter · Firm: DARLENE RICHESON & ASSOCIATES
HR 1296 HB3200
Client expense: — · Firm income: $10,000
Matched citations: HR 1296
Medicare Advanced Laboratory Diagnostics Act of 2007
2008 · third_quarter · Firm: DARLENE RICHESON & ASSOCIATES
H.R. 1321- All provisions CMS- 1404-P
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1321
Pathway for Biosimilars Act
2008 · second_quarter · Firm: DARLENE RICHESON & ASSOCIATES
HR 5629- Pathways for Biosimilars Act of 2008; all provisions CMS-Competitive Acquisition-DMEPOS HIV/AIDS
Client expense: — · Firm income: $30,000
Matched citations: HR 5629
Patient Protection and Innovative Biologic Medicines Act of 2007
2008 · first_quarter · Firm: DARLENE RICHESON & ASSOCIATES
H.R. 5629 Pathways for Biosimilars Act of 2008 ; all provisions H.R. 1956 Patient Protection and Innovative Biologic Medicines Act of 2007; all provisions FDA Appropriations HIV/AIDS
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1956
Pathway for Biosimilars Act
2008 · first_quarter · Firm: DARLENE RICHESON & ASSOCIATES
H.R. 5629 Pathways for Biosimilars Act of 2008 ; all provisions H.R. 1956 Patient Protection and Innovative Biologic Medicines Act of 2007; all provisions FDA Appropriations HIV/AIDS
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5629
Source: Senate LDA